SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

GIORDANI, Fabíola et al. Vigilância de eventos adversos a medicamentos em hospitais: aplicação e desempenho de rastreadores. Rev. bras. epidemiol. [online]. 2012, vol.15, n.3, pp. 455-467. ISSN 1415-790X.  http://dx.doi.org/10.1590/S1415-790X2012000300002.

    1. Baker GR, Norton PG, Flintoft V, Blais R, Brown A, Cox J et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004; 170(11): 1678-86. [ Links ]

    2. Mendes W, Martins M, Rozenfeld S, Travassos C. The assessment of adverse events in hospitals in Brazil. Int J Qual Health Care. 2009; 21(4): 279-84. [ Links ]

    3. Cano FG, Rozenfeld S. Adverse drug events in hospitals: a systematic review. Cad Saude Publica 2009; 25(S3): 360-72. [ Links ]

    4. Romero AV, Malone DC. Accuracy of adverse-drug-event reports collected using an automated dispensing system. Am J Health Syst Pharm 2005; 62(13): 1375-80. [ Links ]

    5. Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother 2005; 39(7-8): 1169-74. [ Links ]

    6. Otero-López MJ, Alonso-Hernández P, Maderuelo-Fernandez JA, Garrido-Corro B, Domínguez-Gil A, Sánchez-Rodríguez A. Acontecimientos adversos prevenibles causados por medicamentos en pacientes hospitalizados. Med Clin (Barc) 2006; 126(3): 81-7. [ Links ]

    7. Otero MJ, Dominguez-Gil A. Acontecimientos adversos por medicamentos: una patologia emergente. Farm Hosp 2000; 24(4): 258-66. [ Links ]

    8. Franklin BD, Birch S, Schachter M, Barber N. Testing a trigger tool as a method of detecting harm from medication errors in a UK hospital: a pilot study. Int J Pharm Pract. 2010; 18(5): 305-11. [ Links ]

    9. Institute for Healthcare Improvement (IHI). Trigger tool for measuring adverse drug events. 2004. Disponível em http://www.ihi.org/NR/rdonlyres/8D970CE4-BF8C-4F35-9BC1-51358FC8B43F/2222/TriggerToolforMeasuringAdverseDrugEventsCorrected1.pdf. [Acessado em 7 de dezembro de 2010] [ Links ]

    10. Roque HE, Melo ECP. Adaptação dos critérios de avaliação de eventos adversos a medicamentos para uso em um hospital público no Estado do Rio de Janeiro. Rev Bras Epidemiol 2010; 13(4): 607-19. [ Links ]

    11 Rozenfeld S, Chaves SM, Reis LG, Martins M, Travassos C, Mendes W et al. Adverse effects from drugs in a public hospital: pilot study. Rev Saude Publica 2009; 43(5): 887-90. [ Links ]

    12. Resar RK, Rozich JD, Classen D. Methodology and rationale for the measurement of harm with trigger tools. Qual Saf Health Care 2003; 12(S2): 39-45. [ Links ]

    13. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care 2003; 12(3): 194-200. [ Links ]

    14. Committee of Experts on Management of Safety and Quality in Health Care (SP-SQS). Expert group on safe medication practices. Glossary of terms related to patient and medication safety. World Health Organization; 2005. Disponível em http://www.who.int/patientsafety/highlights/COE_patient_and_medication_safety_gl.pdf [Acessado em 7 de janeiro de 2011] [ Links ]

    15. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45. [ Links ]

    16. Lauritsen JM. (Ed.) EpiData Data Entry, Data Management and basic Statistical Analysis System. Odense Denmark, EpiData Association; 2000-2008. Disponível em http://www. epidata.dk [Acessado em 12 de junho de 2010] [ Links ]

    17. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Group Crit Care 2004; 8(4): R204-12. [ Links ]

    18. Handler SM, Altman RL, Perera S, Hanlon JT, Studenski SA, Bost JE et al. A systematic review of the performance characteristics of clinical event monitor signals used to detect adverse drug events in the hospital setting. J Am Med Inform Assoc 2007; 14(4): 451-8. [ Links ]

    19. Zegers M, de Bruijne MC, Wagner C, Groenewegen PP, van der Wal G, de Vet HC. The inter-rater agreement of retrospective assessments of adverse events does not improve with two reviewers per patient record. J Clin Epidemiol 2010; 63(1): 94-102. [ Links ]

    20. Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc 2006; 13(4): 372-7. [ Links ]

    21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-83. [ Links ]

    22. Field TS, Gurwitz JH, Harrold LR, Rothschild J, DeBellis KR, Seger AC et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52(8): 1349-54. [ Links ]